Multisensory dysfunction is tied to an increased risk of developing dementia or Alzheimer’s disease (AD) in older adults, thus underlining the importance of sensory evaluation in this patient subgroup and among those at risk of developing neurodegenerative illnesses, according to studies presented at AAIC 2019.
Biomarkers in the blood may present a new opportunity for developing a simple, noninvasive, and inexpensive screening test for Alzheimer’s disease (AD), according to studies presented at the Alzheimer's Association International Conference (AAIC) 2019.
A recent analysis of 1,289 individuals across normal, overweight and obese Body Mass Index (BMI) ranges demonstrated that higher BMI and waist circumference values were significantly associated with thinner brain cortices.
A recently published prospective cohort study involving 2,000 individuals ≥70 years of age demonstrated that engaging in mentally stimulating activities, such as computer use, social and craft activities and playing games, was associated with a decreased risk of mild cognitive impairment (MCI).
Off-label low dosing of rivaroxaban appears to do more harm than good to Asian patients with atrial fibrillation (AF), with a recent study showing that such a strategy confers an increased risk of ischaemic stroke without reducing that of intracranial haemorrhage (ICH) as compared with on-label dosing.
Sex-specific differences in the way brain regions are connected may influence how tau propagates through the brain and thus, differences in the risk of Alzheimer’s disease between men and women; while participating in the workforce may help stave cognitive decline in women, suggest studies presented at AAIC 2019.
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.